C-H3U4Mirscience Therapeutics
microRNA, oligonucleotides, MIR-Discovery
modulatingrna therapeutic
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-H3U4
C-H3U4C-H3U4microRNA, oligonucleotides, MIR-Discovery
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Mirscience Therapeutics states that it develops personalized RNA therapies for diseases associated with longevity, with the goal of improving patients’ independence, autonomy, well-being, and overall quality of life. The company presents healthy aging as a lifelong process of preserving physical and mental health, and argues that muscular and metabolic diseases are major barriers to healthy aging because they reduce well-being and autonomy while increasing health-related costs and mortality.
SourceMirscience Therapeutics states that diseases associated with longevity should be addressed through personalized RNA therapies aimed at difficult-to-drug targets, with the goal of improving patients’ independence, autonomy, well-being, and overall quality of life. The company frames healthy aging as a lifelong process of preserving physical and mental health, and it emphasizes muscular and metabolic diseases as major drivers of lost autonomy, reduced well-being, higher health-related costs, and mortality.
SourceMirscience Therapeutics states that diseases associated with longevity, especially muscular and metabolic diseases, are major drivers of reduced well-being and autonomy in aging patients, while healthy aging depends on preserving physical and mental health, independence, and overall well-being across life. The company presents personalized RNA therapies based on microRNAs as a way to act on difficult therapeutic targets and expand treatment options for unmet medical needs that affect patients’ quality of life.
Source